Creutzfeldt-Jakob Disease: Rising Prions Diseases

https://twitter.com/Perpetualmaniac/status/1437775472499253249/photo/1 “Analysis of the Pfizer vaccine against COVID-19 identified two  potential risk factors for inducing prion disease in humans. The RNA  sequence in the vaccine contains sequences believed to induce  TDP-43 and FUS to aggregate in their prion based conformation  leading to the development of common neurodegenerative diseases.” Read more here:  https://thecovidblog.com/2021/09/15/clint-bearden-55-year-old-louisiana-oil-worker-diagnosed-with-dementia-10-days-after-second-pfizer-mrna-injection/

 Learn about Prions at  https://prions.rip/ Those interested in Prion Disease on Twitter: https://twitter.com/veryvirology https://twitter.com/Parsifaler

https://www.bloomberg.com/news/articles/2021-03-21/astrazeneca-r-d-oncology-chief-jos-baselga-dies-at-61  https://www.fiercebiotech.com/biotech/life-science-industry-mourns-death-astrazeneca-s-cancer-r-d-chief-jose-baselga According to local reports from his native Spain, Baselga died from Creutzfeldt-Jakob disease, an incredibly rare and fatal condition causing brain damage that worsens rapidly over time. A little over two years ago, Baselga was  brought on board  at AstraZeneca to run its oncology R&D unit which, pre-COVID-19, was its biggest focus and future growth driver. He helped shape the Daiichi Sankyo collaboration centered around its antibody-drug conjugate cancer med Enhertu (trastuzumab deruxtecan), which later nabbed an FDA approval. He came to the U.K.-based Big Pharma in early 2019 following his role as physician-in-chief at the Memorial Sloan Kettering Cancer Center and a stint as president of the American Association for Cancer Research (AAC...

 https://childrenshealthdefense.org/defender/cheryl-cohen-dies-rare-brain-disease-second-dose-pfizer-covid-shot/ Woman Dies of Rare Brain Disease Within 3 Months of Second Pfizer Shot, Doctor Says Vaccine Could Be Responsible In an exclusive interview with The Defender, Gianni Cohen said her mother, Cheryl Cohen, developed Creutzfeldt-Jakob Disease after getting the Pfizer vaccine, and died within three months of her second dose. By  Megan Redshaw 122 Link copied The Defender is experiencing censorship  on many social channels. Be sure to stay in touch with the news that matters by  subscribing to our top news of the day .  It's free . Cheryl Cohen, a healthy 64-year-old woman from Florida, died three months after her second dose of Pfizer’s COVID vaccine. According to Chery’s daughter, Gianni Cohen, her mother suddenly developed  Creutzfeldt-Jakob Disease  (CJD) — a rare, degenerative and fatal brain disorder — soon after she was vaccinated. In an exc...

 https://www.mayoclinic.org/diseases-conditions/creutzfeldt-jakob-disease/symptoms-causes/syc-20371226 All types of  CJD  are serious, but very rare. Worldwide, about one to two cases of  CJD  are diagnosed per million people each year, most often in older adults Overview Creutzfeldt-Jakob (KROITS-felt YAH-kobe) disease (CJD) is a degenerative brain disorder that leads to dementia and, ultimately, death. Creutzfeldt-Jakob disease symptoms can be similar to those of other dementia-like brain disorders, such as Alzheimer's disease. But Creutzfeldt-Jakob disease usually progresses much more rapidly. CJD  captured public attention in the 1990s when some people in the United Kingdom developed a form of the disease — variant CJD (vCJD) — after eating meat from diseased cattle. However, "classic" Creutzfeldt-Jakob disease hasn't been linked to contaminated beef. All types of  CJD  are serious, but very rare. Worldwide, about one to two cases of  CJD...

 https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets/Creutzfeldt-Jakob-Disease-Fact-Sheet What is Creutzfeldt-Jakob disease? Creutzfeldt-Jakob disease (CJD) is a rare, degenerative, fatal brain disorder.  It affects about one person in every one million per year worldwide; in the United States there are about 350 cases per year.  CJD usually appears in later life and runs a rapid course.  Typical onset of symptoms occurs at about age 60, and about 70 percent of individuals die within one year.  In the early stages of the disease, people may have failing memory, behavioral changes, lack of coordination, and visual disturbances.  As the illness progresses, mental deterioration becomes pronounced and involuntary movements, blindness, weakness of extremities, and coma may occur. There are three major categories of CJD. In  sporadic CJD , the disease appears even though the person has no known risk factors for the disease. This is by...